A distal intergenic region controls pancreatic endocrine differentiation by acting as a transcriptional enhancer and as a polycomb response element-Reference-Cited by-同舟云学术

A distal intergenic region controls pancreatic endocrine differentiation by acting as a transcriptional enhancer and as a polycomb response element

Published:2017-02-22 Issue:2 Volume:12 Page:e0171508
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

van Arensbergen Joris,Dussaud Sebastien,Pardanaud-Glavieux Corinne,García-Hurtado Javier,Sauty Claire,Guerci Aline,Ferrer Jorge,Ravassard Philippe^ORCID

Funder

Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques (ALFEDIAM)

Wellcome Trust Senior Investigator Award

Ministerio de Economía y Competitividad

JDRF / INSERM

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

1. Finding distal regulatory elements in the human genome;ND Heintzman;Curr Opin Genet Dev,2009

2. Enhancers: emerging roles in cell fate specification;CT Ong;EMBO Rep,2012

3. The Polycomb complex PRC2 and its mark in life;R Margueron;Nature,2011

4. Polycomb group protein-mediated repression of transcription;L Morey;Trends Biochem Sci,2010

5. Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice;B Schuettengruber;Development,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromatin accessibility differences between alpha, beta, and delta cells identifies common and cell type-specific enhancers;BMC Genomics;2023-04-17

2. Distinct roles for canonical and variant histone H3 lysine-36 in Polycomb silencing;Science Advances;2023-03-03

3. Chromatin accessibility differences between alpha, beta, and delta cells identifies common and cell type-specific enhancers;2022-10-19

4. Distinct roles for canonical and variant histone H3 lysine 36 in Polycomb silencing;2022-10-11

5. Multidimensional chromatin profiling of zebrafish pancreas to uncover and investigate disease-relevant enhancers;Nature Communications;2022-04-11